CPHI logo
  • Products
  • Suppliers
  • Sourcing Requests
  • 中文站
  • Sign in Join free
Post Sourcing Request Post Sourcing Request Sourcing Request List Exhibition
  • Home
  • Products
  • Suppliers
  • Content Hub
  • Industry Insights
  • Service & Membership
  • E-Trade Season
  • For Suppliers

    My Account

    My Online Store

    My EZSourcing

    View Sourcing Requests

    Customer Service

  • For Buyer

    Search Products & Suppliers

    Products Directory Suppliers Discovery Post EZSourcing

    Service

    Buyer Sourcing Event Contact Us

    Quick links

    My Favorites Recent Visit History
  • Industry Data
  • Features
  • Market News
  • Products Guide
  • Brand Story
You are here:   Industry Insights > Market News

Market News

  • CPHI China opens for international partnering after China rises in CPHI Index Market news PharmaSources.comJune 08, 2022
    CPHI & P-MEC China​ opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
  • Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market Market news PharmaSourcesFebruary 02, 2023
    Both the US Skokie and European Rankweil sites address customer needs in early-phase drug development
  • Coriolis Pharma Strengthens its Presence in North America by Appointing Formulation Expert Prof. Dr. Reza Nejadnik to its Scientific Advisory Board Market news PharmaSourcesFebruary 01, 2023
    Prof. Dr. Reza Nejadnik's research at the University of Iowa, College of Pharmacy, is focused on protein pharmaceuticals, their formulation and characterization, and interaction of biologics with interfaces.
  • Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III Market news PharmaSourcesJanuary 26, 2023
    ProBioGen today announced that a Novartis clinical candidate using its antibody-dependent cellular cytotoxicity (ADCC) technology, GlymaxX, has reached Phase III.
  • First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated Market news PharmaSourcesJanuary 23, 2023
    OxSonics Therapeutics, announces that first-in-human clinical data demonstrated that SonoTran® is safe and well-tolerated, with consistent Particle activation observed and mapped using OxSonics’ proprietary “see-as-you-treat” technology.
  • SOTIO Doses First Patient in AURELIO-05 Phase 2 Trial of Nanrilkefusp Alfa in Combination with Cetuximab Market news PharmaSourcesJanuary 19, 2023
    SOTIO Biotech announced today that the first patient was dosed in its Phase 2 AURELIO-05 combination trial of nanrilkefusp alfa (previously known as SOT101), an IL-15 superagonist, and cetuximab in patients with colorectal cancer.
  • osteolabs Successfully Demonstrates Broader Application of its Technology for Chronic Kidney Disease and Bone Metastasis-related Prostate Cancer Market news PharmaSourcesJanuary 19, 2023
    So far osteolabs has successfully applied its proprietary Calcium Isotope Marker Technology for the early detection and therapy monitoring in the field of osteoporosis.
  • Novotech Acquires US-based Drug Development Consulting Firm, CBR International Market news PharmaSourcesJanuary 12, 2023
    Expands Drug Development and FDA Regulatory Expertise
  • Novotech Acquires European CRO, Strengthens Global Operations Market news PharmaSourcesJanuary 12, 2023
    The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has over 250 employees.
  • HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study) Market news PharmaSourcesJanuary 12, 2023
    HighTide Therapeutics Inc. announced the dosing of the first patient in a Phase 2b clinical study evaluating HTD1801 for the treatment of nonalcoholic steatohepatitis ("NASH").
Previous page 1 2 3 4 5 6 7 8 ... 4083 4084 Next page

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
  • Copyright 2006-2023 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
  • Links:
    CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
  • Follow Us:

  • CPHI logo Pharma Sources Insight JUNE2022
  • PharmaSources@imsinoexpo.com
  • +86-13621645194
  • We Want Your Feedback